Echo Therapeutics, Inc. 4/A SEC Filings

Filed On	Filing
23 Nov 2016	Form 4/A: Schoenbart Alan Wayne, INTERIM CEO, CFO AND SECRETARY Received 100,000 shares as a grant or award
22 Mar 2016	Form 4/A: Goldberg Shepard M, Director Granted 150,000 Options (Right to Buy)
22 Mar 2016	Form 4/A: Goldberg Michael M, Director Granted 150,000 Options (Right to Buy)
22 Mar 2016	Form 4/A: Edelman Elazer R, Director Granted 150,000 Options (Right to Buy)
18 May 2015	Form 4/A: Nordlicht Mark, 10% owner and 5 others Disposed of 1,500,000 shares (Other Transaction) · Acquired 420,168 Series F Preferred Stock (Open Market Purchase) ($500K) · Acquired 1 Warrants (Open Market Purchase) · 1 more
09 Jul 2013	Form 4/A: Doman Robert F, Director Received 400 shares as a grant or award · Granted 1,500 Nonqualified Stock Option (right to buy)
09 Jul 2013	Form 4/A: Enright Vincent D, Director Received 400 shares as a grant or award · Granted 1,500 Nonqualified Stock Option (right to buy)
09 Jul 2013	Form 4/A: Smith James Francis, Director Received 400 shares as a grant or award · Granted 1,500 Nonqualified Stock Option (right to buy)
09 Jul 2013	Form 4/A: Grieco William, Director Received 400 shares as a grant or award · Granted 1,500 Nonqualified Stock Option (right to buy)
24 Aug 2006	Form 4/A: Davison Thomas W, Director Received 65,000 shares as a grant or award
20 Dec 2004	Form 4/A: Wigley Michael, Director Bought 117,650 shares ($235K)
01 Jun 2004	Form 4/A: Wigley Michael, Director Acquired 35,000 Series A Preferred Stock (Gift) · Acquired 35,000 Warrants to purchase Common Stock (Gift) · Received 193,840 shares by conversion
06 Oct 2003	Form 4/A: Wigley Michael, Director Acquired 0 Series A Convertible Preferred Stock (Open Market Purchase) · Acquired 0 Common Stock Purchase Warrants(right to buy) (Open Market Purchase)

Comments